Incyte
INCY
#1183
Rank
NZ$33.72 B
Marketcap
NZ$169.47
Share price
-0.40%
Change (1 day)
36.85%
Change (1 year)

Incyte (INCY) - Total assets

Total assets on the balance sheet as of December 2025 : NZ$11.63 Billion

According to Incyte's latest financial reports the company's total assets are NZ$11.63 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Incyte - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31NZ$12.01 B24.45%
2024-12-31NZ$9.65 B-9.99%
2023-12-31NZ$10.72 B16.57%
2022-12-31NZ$9.19 B27.38%
2021-12-31NZ$7.22 B46.35%
2020-12-31NZ$4.93 B-3.01%
2019-12-31NZ$5.08 B29%
2018-12-31NZ$3.94 B21.66%
2017-12-31NZ$3.24 B37.06%
2016-12-31NZ$2.36 B60.71%
2015-12-31NZ$1.47 B44.8%
2014-12-31NZ$1.01 B32.69%
2013-12-31NZ$0.76 B90.74%
2012-12-31NZ$0.40 B-4.71%
2011-12-31NZ$0.42 B-33.58%
2010-12-31NZ$0.63 B-35.3%
2009-12-31NZ$0.98 B144.93%
2008-12-31NZ$0.40 B11.26%
2007-12-31NZ$0.35 B-28.29%
2006-12-31NZ$0.50 B-8.3%
2005-12-31NZ$0.54 B-24.45%
2004-12-31NZ$0.72 B24.07%
2003-12-31NZ$0.58 B-44.66%
2002-12-31NZ$1.05 B-37.91%
2001-12-31NZ$1.69 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
NZ$185.57 B 1,494.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$349.12 B 2,899.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$188.12 B 1,516.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$150.76 B 1,195.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$2.47 B-78.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.94 B-91.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$0.18 B-98.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ$0.16 B-98.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.81 B-93.01%๐Ÿ‡บ๐Ÿ‡ธ USA